Insigneo Advisory Services’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
VCM
N
Insigneo Advisory Services's REGN Position: Q1 2026 in Review
Insigneo Advisory Services reduced its Regeneron Pharmaceuticals (REGN) stake by 1.8% in Q1 2026, selling an estimated $6.13K and leaving 437 shares worth $338K. The position accounts for 0.02% of the portfolio, ranked #467.
Insigneo Advisory Services first reported a position in REGN in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.13M in Q2 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Insigneo Advisory Services held 437 shares of Regeneron Pharmaceuticals worth $338K as of Q1 2026.
- Insigneo Advisory Services sold 8 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $6.13K.
- Regeneron Pharmaceuticals made up 0.02% of Insigneo Advisory Services's portfolio in Q1 2026, its #467 holding.
- Insigneo Advisory Services first reported a position in Regeneron Pharmaceuticals in Q2 2023 and has held it in 12 quarters since.
- Insigneo Advisory Services's Regeneron Pharmaceuticals position peaked at $1.13M in Q2 2024.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Insigneo Advisory Services's 13F filing for Q1 2026, filed 12 May 2026.